#CityTherapeutics has finalised its #IPO, raising $200 million for a pipeline of #RNAinterference (RNAi) therapies headed by a novel #anticoagulant drug.
@pharmaphorum.bsky.social@pharmaphorum.bsky.social
@pharmaphorum.bsky.social#CityTherapeutics has finalised its #IPO, raising $200 million for a pipeline of #RNAinterference (RNAi) therapies headed by a novel #anticoagulant drug.